No quarterly revenue total was found in CARTESIAN GROWTH CORPORATION II's SEC filings.
Cartesian Growth Corporation II (RENEF) files with the SEC under industry code 6770, Blank Checks.
Revenue
—
Net income
$-699,615
-359.6% vs year-ago quarter
Operating cash flow
$-206,270
-103.0% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- RENEF (OTC), REEUF (OTC), REEWF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1889112
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$527,434 | -$242,432 | -$270,601 | -$203,228 | -$262,245 |
| Net income | -$699,615 | $3.1M | -$2.3M | $338,160 | -$152,231 |
| Operating cash flow | -$206,270 | -$57,566 | -$331,270 | -$185,509 | -$101,620 |
| Total assets | $38.6M | $38.4M | $38.3M | $88.6M | $87.4M |
| Total liabilities | $24.7M | $23.7M | $26.7M | $23.5M | $22.7M |
| Stockholders' equity | -$24.4M | -$23.5M | -$26.3M | -$23.4M | -$22.3M |
| Cash and investments | $149,017 | $105,287 | $38.1M | $88.5M | $87.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt
|
Oct 14, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Aug 4, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 27, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Other events
|
Jul 24, 2026 | Jul 24, 2026 |
All 148 Cartesian Growth Corporation II SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.